Trial
NCT02483936
Efficacy and Safety of Olmesartan Associated With Chlorthalidone Versus Benicar HCT® in Essential Hypertension Control
Phase IIIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
EMS
Collaborators
—
Condition
Arterial Hypertension
Intervention
Olmesartan medoxomil 40mg + chlorthalidone 12,5mg
Why stopped
Decided by Sponsor
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-08